Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

The aging kidney and the nephrotoxic effects of mercury.

Bridges CC, Zalups RK.

J Toxicol Environ Health B Crit Rev. 2017;20(2):55-80. doi: 10.1080/10937404.2016.1243501. Epub 2017 Feb 7. Review.

2.

Compensatory Renal Hypertrophy and the Uptake of Cysteine S-Conjugates of Hg2+ in Isolated S2 Proximal Tubular Segments.

Bridges CC, Barfuss DW, Joshee L, Zalups RK.

Toxicol Sci. 2016 Dec;154(2):278-288. Epub 2016 Aug 25.

3.

Mechanisms involved in the transport of mercuric ions in target tissues.

Bridges CC, Zalups RK.

Arch Toxicol. 2017 Jan;91(1):63-81. doi: 10.1007/s00204-016-1803-y. Epub 2016 Jul 15. Review.

4.

Compensatory renal hypertrophy and the handling of an acute nephrotoxicant in a model of aging.

Oliveira CS, Joshee L, Zalups RK, Bridges CC.

Exp Gerontol. 2016 Mar;75:16-23. doi: 10.1016/j.exger.2016.01.001. Epub 2016 Jan 6.

5.

Disposition of inorganic mercury in pregnant rats and their offspring.

Oliveira CS, Joshee L, Zalups RK, Pereira ME, Bridges CC.

Toxicology. 2015 Sep 1;335:62-71. doi: 10.1016/j.tox.2015.07.006. Epub 2015 Jul 18.

6.

Toxicological significance of renal Bcrp: Another potential transporter in the elimination of mercuric ions from proximal tubular cells.

Bridges CC, Zalups RK, Joshee L.

Toxicol Appl Pharmacol. 2015 Jun 1;285(2):110-7. doi: 10.1016/j.taap.2015.03.027. Epub 2015 Apr 11.

7.

Novel Hg2+-induced nephropathy in rats and mice lacking Mrp2: evidence of axial heterogeneity in the handling of Hg2+ along the proximal tubule.

Zalups RK, Joshee L, Bridges CC.

Toxicol Sci. 2014 Nov;142(1):250-60. doi: 10.1093/toxsci/kfu171. Epub 2014 Aug 21.

8.

Aging and the disposition and toxicity of mercury in rats.

Bridges CC, Joshee L, Zalups RK.

Exp Gerontol. 2014 May;53:31-9. doi: 10.1016/j.exger.2014.02.006. Epub 2014 Feb 16.

9.

Structural characterization of 1,3-propanedithiols that feature carboxylic acids: Homologues of mercury chelating agents.

Sattler W, Palmer JH, Bridges CC, Joshee L, Zalups RK, Parkin G.

Polyhedron. 2013 Nov 12;64. doi: 10.1016/j.poly.2013.05.012.

10.

Glutathione status and the renal elimination of inorganic mercury in the Mrp2(-/-) mouse.

Bridges CC, Joshee L, van den Heuvel JJ, Russel FG, Zalups RK.

PLoS One. 2013 Sep 5;8(9):e73559. doi: 10.1371/journal.pone.0073559. eCollection 2013.

11.

Placental and fetal disposition of mercuric ions in rats exposed to methylmercury: role of Mrp2.

Bridges CC, Joshee L, Zalups RK.

Reprod Toxicol. 2012 Dec;34(4):628-34. doi: 10.1016/j.reprotox.2012.10.001. Epub 2012 Oct 8.

12.

Luminal transport of thiol S-conjugates of methylmercury in isolated perfused rabbit renal proximal tubules.

Wang Y, Zalups RK, Barfuss DW.

Toxicol Lett. 2012 Sep 3;213(2):203-10. doi: 10.1016/j.toxlet.2012.07.003. Epub 2012 Jul 16.

13.

Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.

Zalups RK, Bridges CC.

Chem Res Toxicol. 2012 Sep 17;25(9):1825-38. doi: 10.1021/tx3001847. Epub 2012 Jun 15. Review.

14.

New insights into the metabolism of organomercury compounds: mercury-containing cysteine S-conjugates are substrates of human glutamine transaminase K and potent inactivators of cystathionine γ-lyase.

Bridges CC, Krasnikov BF, Joshee L, Pinto JT, Hallen A, Li J, Zalups RK, Cooper AJ.

Arch Biochem Biophys. 2012 Jan 1;517(1):20-9. doi: 10.1016/j.abb.2011.11.002. Epub 2011 Nov 10.

15.

MRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercury.

Bridges CC, Joshee L, Zalups RK.

Toxicol Appl Pharmacol. 2011 Feb 15;251(1):50-8. doi: 10.1016/j.taap.2010.11.015. Epub 2010 Dec 4.

16.

Transport of inorganic mercury and methylmercury in target tissues and organs.

Bridges CC, Zalups RK.

J Toxicol Environ Health B Crit Rev. 2010;13(5):385-410. doi: 10.1080/10937401003673750. Review.

PMID:
20582853
17.
18.

Potential mechanisms involved in the absorptive transport of cadmium in isolated perfused rabbit renal proximal tubules.

Wang Y, Zalups RK, Barfuss DW.

Toxicol Lett. 2010 Mar 1;193(1):61-8. doi: 10.1016/j.toxlet.2009.12.007. Epub 2009 Dec 16.

19.

Mercury toxicokinetics--dependency on strain and gender.

Ekstrand J, Nielsen JB, Havarinasab S, Zalups RK, Söderkvist P, Hultman P.

Toxicol Appl Pharmacol. 2010 Mar 15;243(3):283-91. doi: 10.1016/j.taap.2009.08.026. Epub 2009 Sep 2.

PMID:
19732784
20.

Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.

Bridges CC, Joshee L, Zalups RK.

Placenta. 2009 Sep;30(9):800-5. doi: 10.1016/j.placenta.2009.06.005. Epub 2009 Jul 16.

21.

MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA.

Zalups RK, Bridges CC.

Toxicol Appl Pharmacol. 2009 Feb 15;235(1):10-7. doi: 10.1016/j.taap.2008.11.003. Epub 2008 Nov 19.

PMID:
19063911
22.

MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.

Bridges CC, Joshee L, Zalups RK.

Toxicol Sci. 2008 Sep;105(1):211-20. doi: 10.1093/toxsci/kfn107. Epub 2008 May 28.

23.
24.

Transport of thiol-conjugates of inorganic mercury in human retinal pigment epithelial cells.

Bridges CC, Battle JR, Zalups RK.

Toxicol Appl Pharmacol. 2007 Jun 1;221(2):251-60. Epub 2007 Mar 23.

25.

Mouse monocytes (RAW CELLS) and the handling of cysteine and homocysteine S-conjugates of inorganic mercury and methylmercury.

Zalups RK, Koropatnick J, Joshee L.

J Toxicol Environ Health A. 2007 May 15;70(10):799-809.

PMID:
17454556
26.

Molecular mimicry as a mechanism for the uptake of cysteine S-conjugates of methylmercury and inorganic mercury.

Bridges CC, Zalups RK.

Chem Res Toxicol. 2006 Sep;19(9):1117-8; author reply 1118-20. No abstract available.

PMID:
16978013
27.

Influence of compensatory renal growth on susceptibility of primary cultures of renal cells to chemically induced injury.

Lash LH, Putt DA, Zalups RK.

Toxicol Sci. 2006 Dec;94(2):417-27. Epub 2006 Sep 12.

PMID:
16968887
28.

System b0,+ and the transport of thiol-s-conjugates of methylmercury.

Bridges CC, Zalups RK.

J Pharmacol Exp Ther. 2006 Nov;319(2):948-56. Epub 2006 Aug 22.

PMID:
16926263
29.

Cystine alters the renal and hepatic disposition of inorganic mercury and plasma thiol status.

Zalups RK, Lash LH.

Toxicol Appl Pharmacol. 2006 Jul 1;214(1):88-97. Epub 2006 Feb 8.

PMID:
16466761
30.
31.
32.
33.
34.
35.
36.

Molecular and ionic mimicry and the transport of toxic metals.

Bridges CC, Zalups RK.

Toxicol Appl Pharmacol. 2005 May 1;204(3):274-308. Review.

37.
39.
40.

Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts.

Butcher HL, Kennette WA, Collins O, Zalups RK, Koropatnick J.

J Pharmacol Exp Ther. 2004 Aug;310(2):589-98. Epub 2004 Mar 23.

PMID:
15039454
41.
42.

Molecular handling of cadmium in transporting epithelia.

Zalups RK, Ahmad S.

Toxicol Appl Pharmacol. 2003 Feb 1;186(3):163-88. Review.

PMID:
12620369
43.

Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells.

Aslamkhan AG, Han YH, Yang XP, Zalups RK, Pritchard JB.

Mol Pharmacol. 2003 Mar;63(3):590-6.

PMID:
12606766
44.
45.
46.

Amino acid transporters involved in luminal transport of mercuric conjugates of cysteine in rabbit proximal tubule.

Cannon VT, Zalups RK, Barfuss DW.

J Pharmacol Exp Ther. 2001 Aug;298(2):780-9.

PMID:
11454942
47.

Functional and toxicological characteristics of isolated renal mitochondria: impact of compensatory renal growth.

Lash LH, Putt DA, Horky SJ 3rd, Zalups RK.

Biochem Pharmacol. 2001 Aug 1;62(3):383-95.

PMID:
11434913
48.
49.
50.

Supplemental Content

Loading ...
Support Center